Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2010
May 2010, Vol 1, No 1
May 2010, Vol 1, No 1
Compendia: Powerful Tools, Wrong Job
By
Lynn Nishida, RPh
Value-Based Care
,
VBCC Perspectives
May 2010, Vol 1, No 1
At the most basic level, compendia are drug information resources intended to aid clinicians in making “informed treatment decisions, especially in difficult and complex cases.”
1
They were not intended for use in determining reimbursement of medications for the public and private healthcare insurance sectors. Nevertheless, this responsibility was assigned by the Centers for Medicare & Medicaid Services (CMS) in a 1993 law that requires Medicare plans to use 1 of 4 national compendia to determine coverage and pay for “off-label uses of anticancer drugs for Medicare beneficiaries.”
Read Article
Oncology Pharmacy Reimbursement Issues in 2010
HOPA Conference
May 2010, Vol 1, No 1
New Orleans, LA—As reimbursement for services continues to decline, oncology pharmacists must be proactive and develop a strategy to minimize losses, said Steven L. D’Amato, RPh, a clinical pharmacy specialist with the Maine Center for Cancer Medicine, Scarborough, Me, at a presentation at the annual meeting of the Hematology/Oncology Pharmacy Association (HOPA).
Read Article
Healthcare Reform Through the Eyes of Joseph S. Bailes, MD
HOPA Conference
May 2010, Vol 1, No 1
New Orleans, LA—The Patient Protection and Affordable Care Act, ie, “health care reform,” was recently passed, but oncologists and those who pay for their services are still wondering what’s in store for them.
Read Article
Traditional Managed Care Tools Just Don’t Work in Oncology
By
Peter G. Ellis, MD
Value-Based Care
,
VBCC Perspectives
May 2010, Vol 1, No 1
As payers focus on the rising cancer care spend, they are turning to tools previously applied to other diseases. Each seems to have potential, but upon closer review, these have fundamental shortcomings when used for cancer.
Read Article
Community Cancer Centers Face Economy’s Impact
ACCC Conference
May 2010, Vol 1, No 1
Baltimore, MD—The preliminary results of a 2009 survey on cancer care trends among community hospital cancer centers indicates the growing impact of the recession, with data showing a greater inability of patients to pay for cancer care and a freezing of plans to purchase new equipment.
Read Article
Get Ready for Comparative Effectiveness Research
ACCC Conference
,
Comparative Effectiveness Research
May 2010, Vol 1, No 1
Baltimore, MD—Comparative effectiveness research (CER) is at the forefront of new cost-control efforts, according to experts speaking at a panel discussion at the Asso ciation of Community Cancer Centers’ (ACCC) 36th Annual National Meeting.
Read Article
Radiation and Reimbursement Concerns Dog Diagnostic Imaging
ACCC Conference
May 2010, Vol 1, No 1
Baltimore, MD—Although majortechnological advances continue in the diagnostic imaging arena, heightenedconcern over radiation overdoses,steep prices for equipment, andquestions about whether the newtechnologies will be reimbursed posechallenges for the field.
Read Article
Foreign Cancer Care Offers a Mirror to Our Own
ACCC Conference
May 2010, Vol 1, No 1
Baltimore, MD—In light of ongoing discussions on healthcare and its reform in the United States, an examination of how care is financed and delivered in other parts of the world could provide a useful contrast for our own national deliberations.
Read Article
Evidence-based Medicine: A First Step on the Path to Value
Value-Based Care
,
VBCC Perspectives
May 2010, Vol 1, No 1
The 2007 annual meeting summary of the Institute of Medicine (IOM) succinctly highlighted the issue of variability in care.
Read Article
SEER-Medicare Database Analysis Confirms Expensive Prostate Cancers Gaining Supremacy
By
Rosemary Frei, MSc
May 2010, Vol 1, No 1
San Francisco, CA—The popularity of minimally invasive radical prostatectomy (MIRP), intensity-modulated radiation therapy (IMRT), and of brachytherapy combined with IMRT for prostate cancer started to take off after 2002, a new database analysis has confirmed.
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma